Advertisement
New Zealand markets closed
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NZD/USD

    0.5892
    -0.0013 (-0.22%)
     
  • NZD/EUR

    0.5523
    -0.0022 (-0.39%)
     
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • OIL

    83.24
    +0.51 (+0.62%)
     
  • GOLD

    2,406.70
    +8.70 (+0.36%)
     
  • NASDAQ

    17,037.65
    -356.67 (-2.05%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • Dow Jones

    37,986.40
    +211.02 (+0.56%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • NZD/JPY

    91.0710
    -0.1830 (-0.20%)
     

Global Electronic Trial Master File (eTMF) Market to Surpass US$ 1,701.3 Million by 2028, Says Coherent Market Insights (CMI)

SEATTLE, Jan. 19, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global electronic trial master file (eTMF) market is estimated to be valued at US$ 939.6 million in 2021, exhibiting a CAGR of 8.9% during the forecast period (2021-2028).

Key Trends and Analysis of the Global Electronic Trial Master File (eTMF) Market:

Major market players are focusing on business development strategies such as product launch, acquisition, and agreement, which is expected to propel the market growth over the forecast period. For instance, in March 2021, Phlexglobal, a provider of intelligent software for regulatory data management, launched the software PhlexTMF. It is a novel software that addresses the growing pharmaceutical industry's demand for readily inspectable storage of the Trial Master File (TMF) after a clinical trial study has been completed. It bridges the compliance gap by enabling secure and convenient eTMF access to data of clinical studies from any location at any time.

Request for Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/507

Key Market Takeaways:

The global electronic trial master file (eTMF) market is expected to exhibit a CAGR of 8.9% during the forecast period, owing to the increasing merger and collaboration agreements between the key players. For instance, in August 2019, TransPerfect, a software solution provider established a partnership with Symphogen, a biotechnology company. Symphogen has chosen TransPerfect's Trial Interactive (TI) GlobalLearn learning management system to provide important compliance-focused training sessions for research workers in order to assure regulatory compliance and overall operational excellence.

ADVERTISEMENT

Among product type, software segment is estimated to account for the largest market share in the global electronic trial master file (eTMF) market in 2021. Market players are indulged in inorganic activities such as partnerships, in order to launch new eTMF software, which is expected to drive the growth of the software segment over the forecast period. For instance, in August 2021, Alimentiv, Inc., a contract research organization (CRO), entered into a partnership with Veeva Vault, a content management platform and launched a new eTMF solution, to improve efficiency, simplify workflows, and provide transparency into the real-time status of the TMF.

Among deployment type, web/cloud segment is expected to account for the largest market share in the global electronic trial master file (eTMF) market, owing to the increasing adoption of cloud-based eTMF software by biotechnology companies. For instance, in 2017, Medidata, the global provider of cloud-based solutions and data analytics for clinical research, announced that Horizon Pharma plc, a biopharmaceutical company, selected the Medidata clinical cloud platform to meet its eTMF and study conduct requirements as well as a full suite of solutions for their end-to-end clinical research needs.

On the basis of region, North America is expected to hold a dominant position with the largest market share in the global electronic trial master file (eTMF) market growth over the forecast period, owing to the increasing adoption of electronic trial master (eTMF) file (eTMF) software and services by the medical device companies. For instance, in October 2021, CARMAT, a medical device company, selected Veeva Vault eTMF software of Veeva Systems to simplify trial master file (TMF) management. Vault eTMF will enable CARMAT to actively manage all TMF processes and documents on a single cloud platform for transparency for documentation purposes. This, in turn, will help CARMAT to focus more on patients.

Competitive Landscape:

Key players operating in the global electronic trial master file (eTMF) market include Phlexglobal, Montrium Inc., TransPerfect, IQVIA, Veeva Systems, Clinevo Technologies, Ennov, MasterControl, Inc., ArisGlobal, Florence HC, Medidata, and SureClinical Inc.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/507

Market Segmentation:

  • Global Electronic Trial Master File (eTMF) Market, By Product Type:

    • Software

    • Services

  • Global Electronic Trial Master File (eTMF) Market, By Deployment Type:

    • On-premise

    • Web/Cloud

  • Global Electronic Trial Master File (eTMF) Market, By End User:

    • Biotechnology and Pharmaceutical Companies

    • Contract Research Organizations (CRO’s)

    • Research Institutes

  • Global Electronic Trial Master File (eTMF) Market, By Region:

    • North America

      • By Country

        • U.S.

        • Canada

    • Latin America

      • By Country

        • Brazil

        • Mexico

        • Argentina

        • Rest of Latin America

    • Europe

      • By Country

        • Germany

        • U.K.

        • France

        • Italy

        • Spain

        • Russia

        • Rest of Europe

    • Asia Pacific

      • By Country

        • China

        • India

        • Japan

        • Australia

        • South Korea

        • ASEAN

        • Rest of Asia Pacific

    • Middle East

      • By Country

        • GCC

        • Israel

        • Rest of Middle East

    • Africa

      • By Country/Region

        • South Africa

        • Central Africa

        • North Africa

Related Market Intelligence Reports:

U.S. IV Infusion Products Market, by Product Type (Cannulation (Needles and Catheter), IV Infusion Pump (Gravity Infusion Devices, Volumetric Pump, Syringe Pump, and Others), Infusion Lines (Set) (Gravity IV Set, Gravity IV Set W/Needle Free Connector, and Pump IV Set), and Others), by Stop Cock Type (3 Way Stopcock, Vacuum Stopcocks, Burette Stopcocks, and Others), by Needle Free Connector (Standalone Connectors and Needle-free Extension Sets), by Infusion Site (Peripheral IV, Medline IV, and Central IV), by Application (Pain Management, Antibiotic/Antiviral, Chemotherapy, and Others), and by End User (Ambulatory Surgical Centers, Clinics, Home Care Settings, Hospitals, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Ambulatory Infusion Center Market, by Therapy Type (Blood Product Infusion, Iron Therapy, Steroid Infusion, Immunoglobulin Therapy, Therapeutic Phlebotomy, Plasmapheresis, Clotting Factor Replacement Therapy, and Others), by Application (Chronic Inflammatory Disorders, Neurological Disorders, Cancers, Nutrition Support, and Gastro-intestinal Disorders), by Distribution Channel (Hospital, Clinics, and Home Infusion), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Follow Us: LinkedIn | Twitter

CONTACT: Mr. Shah Senior Client Partner – Business Development Coherent Market Insights Phone: US: +1-206-701-6702 UK: +44-020-8133-4027 Japan: +81-050-5539-1737 India: +91-848-285-0837 Email: sales@coherentmarketinsights.com Website: https://www.coherentmarketinsights.com